Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient
Abstract
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hingorani, M.; Hanson, I.; van Heyningen, V. Aniridia. Eur. J. Hum. Genet. 2012, 20, 1011–1017. [Google Scholar] [CrossRef]
- Kasmann-Kellner, B.; Seitz, B. Congenital aniridia or pax6 syndrome. Ophthalmologe 2014, 111, 1144. [Google Scholar] [CrossRef]
- Vasilyeva, T.A.; Voskresenskaya, A.A.; Pozdeyeva, N.A.; Marakhonov, A.V.; Zinchenko, R.A. Pax6 gene characteristic and causative role of pax6 mutations in inherited eye pathologies. Russ. J. Genet. 2018, 54, 995–1002. [Google Scholar] [CrossRef]
- «Prevalence of Rare Diseases: Bibliographic Data», Orphanet Report Series, Rare Diseases Collection, January 2019, Number 2: Diseases Listed by Decreasing Prevalence, Incidence or Number of Published Cases. Available online: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_decreasing_prevalence_or_cases.pdf (accessed on 12 January 2019).
- Reiser, K.; Whitcomb, C.; Robinson, K.; MacKenzie, M.R. T and b lymphocytes in patients with down’s syndrome. Am. J. Ment. Defic. 1976, 80, 613–619. [Google Scholar]
- Lagan, N.; Huggard, D.; Mc Grane, F.; Leahy, T.R.; Franklin, O.; Roche, E.; Webb, D.; O’Marcaigh, A.; Cox, D.; El-Khuffash, A.; et al. Multiorgan involvement and management in children with down syndrome. Acta Paediatr. 2020, 109, 1096–1111. [Google Scholar] [CrossRef]
- Rosca, I.; Turenschi, A.; Nicolescu, A.; Constantin, A.T.; Canciu, A.M.; Dica, A.D.; Bratila, E.; Coroleuca, C.A.; Nastase, L. Endocrine disorders in a newborn with heterozygous galactosemia, down syndrome and complex cardiac malformation: Case report. Medicina 2023, 59, 856. [Google Scholar] [CrossRef] [PubMed]
- Haseeb, A.; Huynh, E.; ElSheikh, R.H.; ElHawary, A.S.; Scelfo, C.; Ledoux, D.M.; Maidana, D.E.; Elhusseiny, A.M. Down syndrome: A review of ocular manifestations. Ther. Adv. Ophthalmol. 2022, 14, 25158414221101718. [Google Scholar] [CrossRef] [PubMed]
- Cleves, M.A.; Hobbs, C.A.; Cleves, P.A.; Tilford, J.M.; Bird, T.M.; Robbins, J.M. Congenital defects among liveborn infants with down syndrome. Birth Defects Res. A Clin. Mol. Teratol. 2007, 79, 657–663. [Google Scholar] [CrossRef]
- Fries, F.N.; Naray, A.; Munteanu, C.; Stachon, T.; Lagali, N.; Seitz, B.; Szentmary, N.; Kasmann-Kellner, B. A cross-sectional analysis of 556 eyes entering the homburg aniridia centre. Klin. Monatsblätter Augenheilkd. 2023. online ahead of print. [Google Scholar] [CrossRef]
- You, B.; Zhang, X.; Xu, K.; Xie, Y.; Ye, H.; Li, Y. Mutation spectrum of pax6 and clinical findings in 95 chinese patients with aniridia. Mol. Vis. 2020, 26, 226–234. [Google Scholar] [PubMed]
- Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 2015, 17, 405–424. [Google Scholar] [CrossRef] [PubMed]
- Sommer, A.; Eaton, A.P. Achondroplasia and down’s syndrome. J. Med. Genet. 1970, 7, 63–66. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Cela, E.; BenEzra, D. Aniridia and down syndrome. J. Pediatr. Ophthalmol. Strabismus 2000, 37, 369–370. [Google Scholar] [CrossRef]
- Solomon, B.D.; Pineda-Alvarez, D.E.; Balog, J.Z.; Hadley, D.; Gropman, A.L.; Nandagopal, R.; Han, J.C.; Hahn, J.S.; Blain, D.; Brooks, B.; et al. Compound heterozygosity for mutations in pax6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia. Am. J. Med. Genet. A 2009, 149A, 2543–2546. [Google Scholar] [CrossRef] [PubMed]
- Henderson, R.A.; Williamson, K.; Cumming, S.; Clarke, M.P.; Lynch, S.A.; Hanson, I.M.; FitzPatrick, D.R.; Sisodiya, S.; van Heyningen, V. Inherited pax6, nf1 and otx2 mutations in a child with microphthalmia and aniridia. Eur. J. Hum. Genet. 2007, 15, 898–901. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Wilson, D.S.; Guenther, B.; Desplan, C.; Kuriyan, J. High resolution crystal structure of a paired (pax) class cooperative homeodomain dimer on DNA. Cell 1995, 82, 709–719. [Google Scholar] [CrossRef] [PubMed]
- Korenberg, J.R.; Kawashima, H.; Pulst, S.M.; Ikeuchi, T.; Ogasawara, N.; Yamamoto, K.; Schonberg, S.A.; West, R.; Allen, L.; Magenis, E.; et al. Molecular definition of a region of chromosome 21 that causes features of the down syndrome phenotype. Am. J. Hum. Genet. 1990, 47, 236–246. [Google Scholar] [PubMed]
- Letourneau, A.; Santoni, F.A.; Bonilla, X.; Sailani, M.R.; Gonzalez, D.; Kind, J.; Chevalier, C.; Thurman, R.; Sandstrom, R.S.; Hibaoui, Y.; et al. Domains of genome-wide gene expression dysregulation in down’s syndrome. Nature 2014, 508, 345–350. [Google Scholar] [CrossRef]
- Martin, K.R.; Corlett, A.; Dubach, D.; Mustafa, T.; Coleman, H.A.; Parkington, H.C.; Merson, T.D.; Bourne, J.A.; Porta, S.; Arbones, M.L.; et al. Over-expression of rcan1 causes down syndrome-like hippocampal deficits that alter learning and memory. Hum. Mol. Genet. 2012, 21, 3025–3041. [Google Scholar] [CrossRef]
- Maslen, C.L.; Babcock, D.; Robinson, S.W.; Bean, L.J.; Dooley, K.J.; Willour, V.L.; Sherman, S.L. Creld1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in down syndrome. Am. J. Med. Genet. A 2006, 140, 2501–2505. [Google Scholar] [CrossRef]
- de Azevedo Moreira, L.M.; Matos, M.A.; Schiper, P.P.; Carvalho, A.F.; Gomes, I.C.; Rolemberg, J.C.; Ferreira de Lima, R.L.; Toralles, M.B. Co-occurrence of achondroplasia and down syndrome: Genotype/phenotype association. Birth Defects Res. A Clin. Mol. Teratol. 2010, 88, 228–231. [Google Scholar] [CrossRef] [PubMed]
- Antonarakis, S.E.; Skotko, B.G.; Rafii, M.S.; Strydom, A.; Pape, S.E.; Bianchi, D.W.; Sherman, S.L.; Reeves, R.H. Down syndrome. Nat. Rev. Dis. Primers 2020, 6, 9. [Google Scholar] [CrossRef] [PubMed]
- Glaser, T.; Jepeal, L.; Edwards, J.G.; Young, S.R.; Favor, J.; Maas, R.L. Pax6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat. Genet. 1994, 7, 463–471. [Google Scholar] [CrossRef] [PubMed]
- Vasilyeva, T.A.; Voskresenskaya, A.A.; Käsmann-Kellner, B.; Khlebnikova, O.V.; Pozdeyeva, N.A.; Bayazutdinova, G.M.; Kutsev, S.I.; Ginter, E.K.; Semina, E.V.; Marakhonov, A.V.; et al. Molecular analysis of patients with aniridia in russian federation broadens the spectrum of pax6 mutations. Clin. Genet. 2017, 92, 639–644. [Google Scholar] [CrossRef]
- Sun, E.; Kraus, C.L. The ophthalmic manifestations of down syndrome. Children 2023, 10, 341. [Google Scholar] [CrossRef]
- Mazzoni, D.S.; Ackley, R.S.; Nash, D.J. Abnormal pinna type and hearing loss correlations in down’s syndrome. J. Intellect. Disabil. Res. 1994, 38 Pt 6, 549–560. [Google Scholar] [CrossRef]
- Bamiou, D.E.; Campbell, N.G.; Musiek, F.E.; Taylor, R.; Chong, W.K.; Moore, A.; van Heyningen, V.; Free, S.; Sisodiya, S.; Luxon, L.M. Auditory and verbal working memory deficits in a child with congenital aniridia due to a pax6 mutation. Int. J. Audiol. 2007, 46, 196–202. [Google Scholar] [CrossRef]
- Grangeon, L.; Cassinari, K.; Rousseau, S.; Croisile, B.; Formaglio, M.; Moreaud, O.; Boutonnat, J.; Le Meur, N.; Mine, M.; Coste, T.; et al. Early-onset cerebral amyloid angiopathy and alzheimer disease related to an app locus triplication. Neurol. Genet. 2021, 7, e609. [Google Scholar] [CrossRef]
- Ichimata, S.; Martinez-Valbuena, I.; Lee, S.; Li, J.; Karakani, A.M.; Kovacs, G.G. Distinct molecular signatures of amyloid-beta and tau in alzheimer’s disease associated with down syndrome. Int. J. Mol. Sci. 2023, 24, 11596. [Google Scholar] [CrossRef]
- Maurya, S.K.; Mishra, R. Pax6 binds to promoter sequence elements associated with immunological surveillance and energy homeostasis in brain of aging mice. Ann. Neurosci. 2017, 24, 20–25. [Google Scholar] [CrossRef]
- Grant, M.K.; Bobilev, A.M.; Branch, A.; Lauderdale, J.D. Structural and functional consequences of pax6 mutations in the brain: Implications for aniridia. Brain Res. 2021, 1756, 147283. [Google Scholar] [CrossRef]
- Voskresenskaya, A.; Pozdeyeva, N.; Vasilyeva, T.; Batkov, Y.; Shipunov, A.; Gagloev, B.; Zinchenko, R. Clinical and morphological manifestations of aniridia-associated keratopathy on anterior segment optical coherence tomography and in vivo confocal microscopy. Ocul. Surf. 2017, 15, 759–769. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.K.; Kim, M.K.; Oh, J.Y. Corneal abnormalities in congenital aniridia: Congenital central corneal opacity versus aniridia-associated keratopathy. Am. J. Ophthalmol. 2018, 185, 75–80. [Google Scholar] [CrossRef] [PubMed]
- Landsend, E.C.S.; Lagali, N.; Utheim, T.P. Congenital aniridia—A comprehensive review of clinical features and therapeutic approaches. Surv. Ophthalmol. 2021, 66, 1031–1050. [Google Scholar] [CrossRef] [PubMed]
- Moshirfar, M.; Hastings, J.; Ronquillo, Y. Aniridic fibrosis syndrome. In Statpearls; Ineligible Companies: Treasure Island, FL, USA, 2023. [Google Scholar]
- Gimenez-Barcons, M.; Casteras, A.; Armengol Mdel, P.; Porta, E.; Correa, P.A.; Marin, A.; Pujol-Borrell, R.; Colobran, R. Autoimmune predisposition in down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of aire and peripheral antigens. J. Immunol. 2014, 193, 3872–3879. [Google Scholar] [CrossRef] [PubMed]
- Eissa, E.; Afifi, H.H.; Abo-Shanab, A.M.; Thomas, M.M.; Taher, M.B.; Kandil, R.; Kholoussi, N.M. Importance of trec and krec as molecular markers for immunological evaluation of down syndrome children. Sci. Rep. 2023, 13, 15445. [Google Scholar] [CrossRef]
Patients | Patient 1 | Patient 2 | Patient 3 |
---|---|---|---|
Age, gender | A 4-year-old girl | A 4.5-month-old boy | A 4-year-old boy |
Reference | (this study) | [14] | [15] |
Karyotype | 47,XX,+21 | 47,XY,+21 | 47,XY,+21 |
PAX6 genotype | c.[282C>A];[=] | not tested | c.[112C>T];[718C>T] |
Facial features consistent with diagnosis of trisomy 21 | Facial dysmorphism, depressed nasal bridge, hypertelorism, antimongoloid slant and eyelid epicanthal folds, asymmetric eyes due to the left eyeball buphthalmos, open mouth, macroglossia, hypersalivation | Facial dysmorphism, depressed nasal bridge, hypertelorism, antimongoloid slant and eyelid epicanthal folds | Facial dysmorphism, depressed nasal bridge, hypertelorism, antimongoloid slant and eyelid epicanthal folds, asymmetric microphthalmia, open mouth, macroglossia, hypersalivation |
Neurologic status | Myotonic syndrome, reduced tendon reflexes, postural kyphosis abnormality, weakened back muscles, valgus right foot and varus left foot deformities | not tested | Extreme microcephaly, a smooth philtrum |
Developmental delay | Developmental delay | not tested | Severe developmental delay |
Brain structure | Normal brain structure | not tested | Complex structural brain anomaly, corpus callosum agenesis, midline interhemispheric cyst, hypoplastic pons and vermis (absent inferiorly), dysplastic tectum, pituitary and hypothalamic hypoplasia, and a globular (though not fused) basal ganglia |
Eyes | Congenital bilateral complete aniridia | Congenital bilateral complete aniridia | Bilateral extreme microphthalmia without visual function |
Congenital bilateral glaucoma | No glaucoma, normal eye pressure | No data | |
Clear lenses with first signs of developing opacities | Clear lenses | No data | |
Vitreous bodies with first signs of degeneration | Normal vitreous bodies | No data | |
Keratopathy OSCornea opacity OD | Clear cornea without vascularization or other signs of keratopathy | No data | |
Normal anterior chambers | Normal anterior chambers | No data | |
Horizontal nystagmus | Horizontal nystagmus | No data | |
Mild hypoplasia of the optic nerve disks | Mild hypoplasia of the optic nerve disks | No data | |
Foveal hypoplasia | Foveal hypoplasia | No data | |
Albinotic color of both fundi | Subalbinotic changes in both fundi | No data | |
Strabismus | No strabismus | No data | |
Myopia | not tested | No data | |
Hearing | Unilateral hearing loss | Normal hearing | No data |
Heart | Persistent ductus arteriosus, atrial septal defect | Ventricular septal defect, aortic coarctation | No data |
Airway anomalies | Laryngomalacia, breath failure on the first week after birth | Bronchopulmonary dysplasia, breath failure | Choanal atresia |
Renal anomalies | Megaureter | No anomalies | Renal dysplasia with recurrent urinary tract infections |
Endocrine status | Increased TTH level | not tested | Central hypothyroidism Gonadotropin deficiency Cryptorchidism Secondary adrenal insufficiency Insulin-dependent diabetes mellitus without pancreatic anomalies |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vasilyeva, T.A.; Sukhanova, N.V.; Marakhonov, A.V.; Kuzina, N.Y.; Shilova, N.V.; Kadyshev, V.V.; Kutsev, S.I.; Zinchenko, R.A. Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient. Int. J. Mol. Sci. 2023, 24, 15527. https://doi.org/10.3390/ijms242115527
Vasilyeva TA, Sukhanova NV, Marakhonov AV, Kuzina NY, Shilova NV, Kadyshev VV, Kutsev SI, Zinchenko RA. Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient. International Journal of Molecular Sciences. 2023; 24(21):15527. https://doi.org/10.3390/ijms242115527
Chicago/Turabian StyleVasilyeva, Tatyana A., Natella V. Sukhanova, Andrey V. Marakhonov, Natalia Yu. Kuzina, Nadezhda V. Shilova, Vitaly V. Kadyshev, Sergey I. Kutsev, and Rena A. Zinchenko. 2023. "Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient" International Journal of Molecular Sciences 24, no. 21: 15527. https://doi.org/10.3390/ijms242115527
APA StyleVasilyeva, T. A., Sukhanova, N. V., Marakhonov, A. V., Kuzina, N. Y., Shilova, N. V., Kadyshev, V. V., Kutsev, S. I., & Zinchenko, R. A. (2023). Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient. International Journal of Molecular Sciences, 24(21), 15527. https://doi.org/10.3390/ijms242115527